Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

West-Ward Pharmaceuticals Corp.

Division of Hikma Pharmaceuticals PLC
www.west-ward.com

Latest From West-Ward Pharmaceuticals Corp.

Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes

US court finds no obviousness-type double patenting under statute that changed patent term from 17 years from issuance to 20 years from filing; decisions will impact other cases involving patents issued prior to statute.
Generic Drugs Legal Issues

PTAB Clears Path For Earlier Generic Zytiga Launch

Patent Trial and Appeal Board finds that the patent covering the blockbuster prostate cancer drug is unpatentable, which could allow generics to launch at-risk in October once they obtain FDA approval; at least 12 firms have pending ANDAs.

Policy Intellectual Property

Code Cart Crisis: Anatomy Of An Emergency Drug Shortage

How FDA, health care providers, and Pfizer and other drug makers are responding to a shortage of emergency medicines from the fragile, overstressed US sterile injectables sector.

Manufacturing Quality

Emflaza's 505(b)(2) Pathway Review: Rare, But With Precedent

US FDA has relied on 505(b)(2) pathway to approve a small group of 'orphaned orphan' drugs – products without patent protection being used on an informal 'gray market' of personal importation and compassionate use protocols.

Drug Review Profile Drug Approval Standards
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Hikma Pharmaceuticals PLC
  • Senior Management
  • Michael Raya, CEO
    Mohammed Obeidat, CFO
    Brian Hoffmann, Pres.
    Spiro Gavaris, SVP, Sales & Mktg.
  • Contact Info
  • West-Ward Pharmaceuticals Corp.
    Phone: (732) 542-1191
    401 Industrial Way
    Eatontown, NJ 07724
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register